Dx Deals: Labcorp Continues Dealmaking with Incyte Asset Acquisition in Washington State
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
UPMC pathology leader discusses steps the lab takes to combat evolving cyber threats
Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
A lawyer advises medical laboratories on how to improve their avenues for reporting unethical behavior
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight